Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will be presenting at three investor conferences during the month of September.

• Rodman & Renshaw 12th Annual Healthcare Conference in New York City at 10:25 a.m. ET on Monday, September 13, 2010. The webcast link for the live audio and slide presentation will be available at the following website address: http://www.wsw.com/webcast/rrshq18/gern. The presentation will be archived for replay at the same address after the conference for a period of 30 days.
• Stifel Nicolaus Healthcare Conference 2010 in Boston at 11:30 a.m. ET on Thursday, September 16, 2010.
• UBS Global Life Sciences Conference in New York City at 10:30 a.m. ET on Wednesday, September 22, 2010. The webcast link for the live audio and slide presentation will be available in the Events section of Geron’s website at: www.geron.com. The presentation will be archived for replay after the conference for a period of 30 days.

The presentation at the first conference will focus on GRNOPC1, Geron’s human embryonic stem cell-based therapy, recently allowed to proceed to a Phase 1 clinical trial in spinal cord injury. The presentations at the second and third conferences will provide updates on all of Geron’s product development programs, including its telomerase inhibitor drug (imetelstat sodium - GRN163L) and telomerase therapeutic vaccine (GRNVAC1) as well as the company’s human embryonic stem cell development programs for spinal cord injury (GRNOPC1), heart disease (GRNCM1), diabetes (GRNIC1), and osteoarthritis (GRNCHND1), and telomerase activator program (GRN510).

About Geron

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit www.geron.com.